Brain Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are 18 years of age or older
- People who have been diagnosed with a specific type of brain tumour called IDH-wildtype glioblastoma, confirmed through laboratory testing of tissue removed during surgery or biopsy
- People who have been referred to a radiotherapy outpatient clinic to receive one of the standard radiation treatment schedules for this condition
- People who are able to provide written agreement to participate in the trial
Who may not be able to join:
- People for whom an MRI scan (specifically a 3 Tesla MRI machine) is not safe or suitable
- People who cannot receive the contrast dye used during MRI scans, for example due to kidney problems or a known allergy to gadolinium-based contrast agents
- People who have been referred for treatment of glioblastoma that has come back after previous treatment
- People who have previously had radiation treatment to the brain
- People who are unable to provide informed written consent to participate
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Alejandra Méndez Romero, MD, PhD, Erasmus Medical Center
Phone: +31634271995
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Pattern-of-failure analysis
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.